If youve been searching for a brightening soap that works without drying out your skin, this is it
Most of the promotions are from (unregulated) beauticians offering the treatment (unlike doctors and nurses who are regulated), but Lemon Bottle makes bold claims on its own official channels
A second candidate, Eli Lilly's orforglipron, is an oral non-peptide small-molecule GLP-1 receptor agonist that posted positive Phase 3 results yet remained unapproved as of April 2026
For everyone else, including the uninsured, Medicare beneficiaries, and those with insurance that excludes weight loss medications, both brand-name cash-pay and compounded alternatives now offer viable paths to treatment
Novo Nordisk has announced results from the phase 3 REDEFINE 4 trial, a head-to-head study comparing CagriSema (a GLP-1 + amylin combination) with tirzepatide for obesity treatment